Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jacob Austin-Breneman"'
Autor:
Alexandre Reuben, Christine N. Spencer, Peter A. Prieto, Vancheswaran Gopalakrishnan, Sangeetha M. Reddy, John P. Miller, Xizeng Mao, Mariana Petaccia De Macedo, Jiong Chen, Xingzhi Song, Hong Jiang, Pei-Ling Chen, Hannah C. Beird, Haven R. Garber, Whijae Roh, Khalida Wani, Eveline Chen, Cara Haymaker, Marie-Andrée Forget, Latasha D. Little, Curtis Gumbs, Rebecca L. Thornton, Courtney W. Hudgens, Wei-Shen Chen, Jacob Austin-Breneman, Robert Szczepaniak Sloane, Luigi Nezi, Alexandria P. Cogdill, Chantale Bernatchez, Jason Roszik, Patrick Hwu, Scott E. Woodman, Lynda Chin, Hussein Tawbi, Michael A. Davies, Jeffrey E. Gershenwald, Rodabe N. Amaria, Isabella C. Glitza, Adi Diab, Sapna P. Patel, Jianhua Hu, Jeffrey E. Lee, Elizabeth A. Grimm, Michael T. Tetzlaff, Alexander J. Lazar, Ignacio I. Wistuba, Karen Clise-Dwyer, Brett W. Carter, Jianhua Zhang, P. Andrew Futreal, Padmanee Sharma, James P. Allison, Zachary A. Cooper, Jennifer A. Wargo
Publikováno v:
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-11 (2017)
Melanoma: Tumor differences within a patient may explain heterogeneous responses Patients with metastatic melanoma display molecular and immune differences across tumor sites associated with differential drug responses. A team led by Jennifer Wargo f
Externí odkaz:
https://doaj.org/article/95f4f8da81aa4220b7ea3fea4b7af4b6
Autor:
Christine N. Spencer, Michael A. Davies, Victor G. Prieto, Khalida Wani, Sapna Pradyuman Patel, Adi Diab, Ignacio I. Wistuba, Hong Jiang, Isabella C. Glitza, Zachary A. Cooper, Padmanee Sharma, Alexandre Reuben, Lynda Chin, Lawrence N. Kwong, Sangeetha M. Reddy, Lauren E. Haydu, Pei Ling Chen, Jorge Blando, Jacob Austin-Breneman, Qing Chang, Arlene H. Sharpe, Patrick Hwu, Michael T. Tetzlaff, Jeffrey E. Gershenwald, Vancheswaran Gopalakrishnan, Peter A. Prieto, Roland L. Bassett, Wencai Ma, Luis M Vence, Wei Shen Chen, Jianhua Hu, James P. Allison, Mariana Petaccia de Macedo, Alexander J. Lazar, Rodabe N. Amaria, R. Eric Davis, Wen-Jen Hwu, Willem W. Overwijk, Russell J. Broaddus, P. Andrew Futreal, Scott E. Woodman, Jennifer A. Wargo, John P. Miller, Whijae Roh
Publikováno v:
Cancer Discovery. 6:827-837
Immune checkpoint blockade represents a major breakthrough in cancer therapy; however, responses are not universal. Genomic and immune features in pretreatment tumor biopsies have been reported to correlate with response in patients with melanoma and
Autor:
T. Kumar, Jennifer A. Wargo, Sangeetha M. Reddy, Jing Shan Hu, Sapna Pradyuman Patel, Adi Diab, Tiziana Cotechini, Miles C. Andrews, Jacob Austin-Breneman, J. M. Gardner, Lauren E. Haydu, Zachary A. Cooper, V. B. Jensen, P. L. Chen, Carrie R. Daniel, Hussein Abdul-Hassan Tawbi, J. E. Lee, Katayoun Rezvani, Spencer C. Wei, Yu Zhang, James P. Allison, Wei Shen Chen, Amin M. Alousi, Patrick Hwu, Isabella C. Glitza, M. Petaccia de Macedo, Nadim J. Ajami, Jianhua Zhang, R. Szczepaniak Sloane, Luigi Nezi, Jessica Galloway-Peña, Roy F. Chemaly, Scott E. Woodman, Courtney W. Hudgens, Nicolas Pons, Elizabeth M. Burton, E. Sirmans, Diane S. Hutchinson, Alexander J. Lazar, Alexandre Reuben, Rodabe N. Amaria, P.A. Futreal, Alexandria P. Cogdill, Wen-Jen Hwu, Laurence Zitvogel, Vancheswaran Gopalakrishnan, Michael T. Tetzlaff, D. Vicente, Alton G. Swennes, Florencia McAllister, Lisa M. Coussens, Christine N. Spencer, Samuel A. Shelburne, Michael A. Davies, Luis M Vence, Elizabeth J. Shpall, Li Zhao, Pablo C. Okhuysen, Takahiro Tsujikawa, Robert R. Jenq, Pradeep Sharma, T. Manzo, Joseph F. Petrosino, Tatiana Karpinets, Hong Jiang, E. Marcelo Riquelme Sanchez, Jeffrey E. Gershenwald, Peter A. Prieto, K. Hoffman
Publikováno v:
Science
Science, American Association for the Advancement of Science, 2018, 359 (6371), pp.97-103. ⟨10.1126/science.aan4236⟩
Science, American Association for the Advancement of Science, 2018, 359 (6371), pp.97-103. ⟨10.1126/science.aan4236⟩
Good bacteria help fight cancer Resident gut bacteria can affect patient responses to cancer immunotherapy (see the Perspective by Jobin). Routy et al. show that antibiotic consumption is associated with poor response to immunotherapeutic PD-1 blocka
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d47c6231d710b1caaeb7f814dc34ed7
https://hal.inrae.fr/hal-02629159
https://hal.inrae.fr/hal-02629159
Autor:
Haven R. Garber, Xingzhi Song, Padmanee Sharma, Alexandria P. Cogdill, Brett W. Carter, Robert Sloane, Jeffrey E. Gershenwald, Xizeng Mao, Zachary A. Cooper, Mariana Petaccia de Macedo, Christine N. Spencer, Jacob Austin-Breneman, Michael A. Davies, Jason Roszik, Ignacio I. Wistuba, Hannah C. Beird, P. Andrew Futreal, Karen Clise-Dwyer, Rodabe N. Amaria, Peter A. Prieto, Curtis Gumbs, James P. Allison, Hong Jiang, Alexandre Reuben, Luigi Nezi, Alexander J. Lazar, Cara Haymaker, Jianhua Hu, Jianhua Zhang, Sapna Pradyuman Patel, Adi Diab, Sangeetha M. Reddy, Rebecca Thornton, Elizabeth A. Grimm, Scott E. Woodman, Latasha Little, Hussein Abdul-Hassan Tawbi, Courtney W. Hudgens, Marie Andrée Forget, Patrick Hwu, Pei Ling Chen, Michael T. Tetzlaff, Jiong Chen, Wei Shen Chen, Isabella C. Glitza, Lynda Chin, Chantale Bernatchez, Jennifer A. Wargo, Jeffrey E. Lee, Vancheswaran Gopalakrishnan, Khalida Wani, Eveline Chen, John P. Miller, Whijae Roh
Publikováno v:
NPJ Genomic Medicine
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-11 (2017)
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-11 (2017)
Appreciation for genomic and immune heterogeneity in cancer has grown though the relationship of these factors to treatment response has not been thoroughly elucidated. To better understand this, we studied a large cohort of melanoma patients treated
Autor:
Jacob Austin-Breneman, Qing Chang, Alexandre Reuben, Mariana Petaccia de Macedo, P. Andrew Futreal, Alexander J. Lazar, Vancheswaran Gopalakrishnan, Padmanee Sharma, Victor G. Prieto, Rodabe N. Amaria, Khalida Wani, Jeffrey E. Gershenwald, Jason Roszik, Sangeetha M. Reddy, Patrick Hwu, James P. Allison, Peter A. Prieto, Pei Ling Chen, Wen-Jen Hwu, Jianhua Hu, Hong Jiang, Latasha Little, Jennifer A. Wargo, Eveline Chen, Hussein Abdul-Hassan Tawbi, John P. Miller, Jianhua Zhang, Christine N. Spencer, Feng Wang, Michael A. Davies, Whijae Roh, Scott E. Woodman, Curtis Gumbs, Michael T. Tetzlaff, Sapna Pradyuman Patel, Adi Diab, Zachary A. Cooper, Wei Shen Chen, Lynda Chin, Isabella C. Glitza
Publikováno v:
Science Translational Medicine. 9
Immune checkpoint blockade produces clinical benefit in many patients. However better biomarkers of response are still needed, and mechanisms of resistance remain incompletely understood. To address this, we recently studied a cohort of melanoma pati
Publikováno v:
Clinical Cancer Research. 21:3102-3104
BRAF inhibitor (BRAFi) treatment enhances antitumor immunity, but is associated with increased intratumoral PD-L1 expression. MEK inhibitors (MEKi) may alter T-cell function; however, recent studies demonstrate preserved T-cell infiltrate during trea
Autor:
Jacob Austin-Breneman, Alexandre Reuben, Vancheswaran Gopalakrishnan, Zachary A. Cooper, Hong Jiang, Heidi Wagner, Jennifer A. Wargo, Christine N. Spencer
Publikováno v:
Journal of Visualized Experiments.
Medical research for human benefit is greatly impeded by the necessity for human tissues and subjects. However, upon obtaining consent for human specimens, precious samples must be handled with the greatest care in order to ensure integrity of organs
Publikováno v:
Annals of translational medicine. 3(18)
Autor:
Courtney W. Hudgens, Alexander J. Lazar, Padmanee Sharma, Mariana Petaccia de Macedo, Pei-Ling Chen, Rodabe N. Amaria, Michael A. Davies, Ignacio I. Wistuba, Lynda Chin, Vancheswaran Gopalakrishnan, Andrew Futreal, Wei-Shen Chen, Haven R. Garber, Patrick Hwu, Hannah Cheung, Karen C. Dwyer, Michael T. Tetzlaff, James P. Allison, Alexandre Reuben, Cara Haymaker, Hong Jiang, John P. Miller, Sapna Pradyuman Patel, Scott E. Woodman, Zachary A. Cooper, Christine N. Spencer, Jennifer A. Wargo, Jianhua Zhang, Jason Roszik, Peter A. Prieto, Jacob Austin-Breneman, Xizeng Mao
Publikováno v:
Cancer Research. 76:2392-2392
There have been significant advances in the treatment of metastatic melanoma through targeted and immunotherapy, however a significant proportion of patients still progress on these regimens with many experiencing mixed responses. Intense research ef
Autor:
Jeffrey E. Gershenwald, Zachary A. Cooper, James P. Allison, Peter A. Prieto, Karen Clise-Dwyer, Dennie T. Frederick, Michael T. Tetzlaff, Cara Haymaker, Sapna Pradyuman Patel, Adi Diab, Padmanee Sharma, Ignacio I. Wistuba, Christine N. Spencer, Michael A. Davies, Alexandre Reuben, Edwin R. Parra, Arlene H. Sharpe, Jacob Austin-Breneman, Isabella C. Glitza, Jaime Rodriguez-Canales, Vancheswaran Gopalakrishnan, Patrick Hwu, Lynda Chin, Scott E. Woodman, Rodabe N. Amaria, Lisa M. Coussens, Jennifer A. Wargo, Ryan J. Sullivan, Keith T. Flaherty, Hong Jiang, Luis M Vence
Publikováno v:
Oncoimmunology
We have made major advances in the treatment of melanoma through the use of targeted therapy and immune checkpoint blockade; however, clinicians are posed with therapeutic dilemmas regarding timing and sequence of therapy. There is a growing apprecia